2013
DOI: 10.1111/apa.12419
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Increase of caffeine and decrease of corticosteroids for extremely low-birthweight infants with respiratory failure from 1997 to 2011

Abstract: Treatment strategies for respiratory failure in ELBW infants have changed significantly between 1997 and 2011.

Search citation statements

Order By: Relevance

Paper Sections

Select...
6
1
0
0

Citation Types

0
6
0
0

Year Published

Range
2015
2015
2023
2023

Publication Types

Select...
5
1
1

Relationship

2
5

Authors

Journals

citations

Cited by 7 publications

(6 citation statements)
references

References 41 publications

0
6
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…Besides, it is used as a somnolytic to counteract drowsiness (e. g., NoDoze and Vivarin each contain 200 mg of caffeine), to enhance seizure duration in electroconvulsive therapy, and to treat respiratory depression in neonates, postprandial hypotension, and obesity. [55][56][57] Similar synergistic additive effects of caffeine and medications also occur in treatments for asthma and gall bladder diseases, attention deficithyperactivity disorder, shortness-of-breath in newborns, low blood pressure, and weight loss. [58][59][60][61][62] Caffeine works by binding to adenosine receptors located in the central and peripheral nervous systems as well as in various organs, such as the heart, and blood vessels.It can have both positive and negative health effects.…”
Section: Caffeine
mentioning
confidence: 87%